VectivBio Holding AG

Overview

• IndustryBiological Products, (No Diagnostic Substances)¹
• HeadquartersV8¹
• Incorporated inSwitzerland²
• Business addressAeschenvorstadt 36, Basel, V8 4051²
• Filer categoryNon-accelerated filer, Emerging growth company²

See how the biggest companies compare on our leaderboards

Corporate structure

VectivBio Holding AG sits at the top of its group. 1 entity on record. Switch between the flow chart and the network, and select any entity to see its details.

Built from major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What VectivBio Holding AG reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

Investments

Intangibles and goodwill

Filings

83 filings to the SEC since October 2021: 2 annual reports, 20 large holders, 61 other. The latest 20:

1. Feb 14, 2024SC 13G/A EDGAR
2. Jul 25, 202315-12G EDGAR
3. Jul 21, 2023EFFECT EDGAR
4. Jul 21, 2023EFFECT EDGAR
5. Jul 21, 2023EFFECT EDGAR
6. Jul 20, 2023POS AM EDGAR
7. Jul 20, 2023POS AM EDGAR
8. Jul 20, 2023POS AM EDGAR
9. Jul 20, 2023S-8 POS EDGAR
10. Jul 20, 2023S-8 POS EDGAR
11. Jul 17, 20236-K EDGAR
12. Jul 10, 202325 EDGAR
13. Jul 7, 2023SC 13D EDGAR
14. Jun 29, 2023SC 14D9/A EDGAR
15. Jun 29, 20236-K EDGAR
16. Jun 26, 2023SC 14D9/A EDGAR
17. Jun 26, 20236-K EDGAR
18. Jun 20, 2023SC 14D9/A EDGAR
19. Jun 16, 2023SC 14D9/A EDGAR
20. Jun 16, 20236-K EDGAR

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

• EVENTIDE ASSET MANAGEMENT, LLCSC 13G/A, 3 filings Feb 14, 2022 to Feb 14, 2024⁵
• Ironwood PharmaceuticalsSC 13D, 1 filing Jul 7, 2023⁶
• Beryl Capital Management LLCSC 13G, 1 filing Jun 5, 2023⁷
• Novo Holdings A/SSC 13G/A, 2 filings Feb 2, 2023 to May 26, 2023⁸
• ORBIMED ADVISORS LLCSC 13D, 3 filings Feb 11, 2022 to May 24, 2023⁹
• CITADEL ADVISORS LLCSC 13G/A, 2 filings Feb 14, 2022 to Feb 14, 2023¹⁰
• Cormorant Asset Management, LPSC 13G/A, 2 filings Jun 17, 2022 to Feb 14, 2023¹¹
• CHI Advisors LLCSC 13G/A, 2 filings Feb 11, 2022 to Feb 13, 2023¹²
• Forbion Growth Opportunities Fund II Cooperatief U.A.SC 13D/A, 2 filings Jul 7, 2022 to Dec 13, 2022¹³
• Bpifrance Participations SASC 13D/A, 2 filings Jun 28, 2022 to Oct 20, 2022¹⁴

SEC filer profile

How VectivBio Holding AG is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

• Name on EDGARVectivBio Holding AG¹
• CIK0001836379
• Filer statusNon-accelerated filer<br>emerging growth company¹
• Incorporated inSwitzerland¹
• Fiscal year endsDecember 31¹
• Industry code (SIC)2836 Biological Products, (No Diagnostic Substances)¹
• SEC reviewing officeOffice of Life Sciences, Division of Corporation Finance¹
• Business addressAeschenvorstadt 36, Basel, V8 4051¹
• Phone41 61 551 30 30¹
• Shares outstanding67,391,790 as of Dec 31, 2022³
• On EDGAR sinceDec 23, 2020¹
• Filings121 in all: 6-K (27), CORRESP (9), SC 13G/A (9), SC 13G (8), EFFECT (7), UPLOAD (7), SC 13D (5), SC 14D9/A (4)¹
  All 33 form types

  SC TO-T/A (4), 424B5 (3), F-3 (3), POS AM (3), SC 13D/A (3), SC TO-C (3), SC14D9C (3), 20-F (2), F-1/A (2), S-8 (2), S-8 POS (2), SEC STAFF LETTER (2), 15-12G (1), 25 (1), 424B4 (1), 6-K/A (1), 8-A12B (1), CERT (1), DRS (1), DRS/A (1), DRSLTR (1), F-1 (1), F-3/A (1), SC 14D9 (1), SC TO-T (1)

• Latest filingsAnnual report (20-F) Apr 19, 2023